ACC.08: Treating very old patients with hypertension, initiating therapy with fixed-dose combinations, and regressing LV hypertrophy -- all good targets for antihypertensive therapy. Or are they? Medscape Cardiology
In the Canadian SMART study, no safety concerns were noted about using large doses of candesartan cilexetil to treat proteinuria. Medscape Medical News
Results from the largest secondary stroke-prevention trial showed that the combination of aspirin and extended-release dipyridamole did not meet criteria for noninferiority vs clopidogrel. In a factorial design, results also showed no effect of telmisartan vs placebo in reducing recurrent stroke, major CVD events, or diabetes. Medscape Medical News
Dr. Keith Ferdinand presents a clinical case study highlighting issues that are unique to the etiology, diagnosis, and management of hypertension in black patients. Medscape Cardiology